Loss of heterozygosity at the mannose 6-phosphate insulin-like growth factor 2 receptor gene correlates with poor differentiation in early breast carcinomas

British Journal of Cancer

Volumn 76, Issue 12, 1997, Pages 1558-1561

  Chappell, S A ^a   Walsh, T ^a   Walker, R A ^a   Shaw, J A ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Breast carcinoma; Loss of heterozygosity; Mannose 6 phosphate insulin like growth factor 2 receptor; Microdissection

Indexed keywords

MANNOSE 6 PHOSPHATE; SOMATOMEDIN B RECEPTOR;

ALLELE; ARTICLE; BREAST CARCINOMA; CARCINOMA IN SITU; CHROMOSOME 6Q; CLINICAL ARTICLE; FEMALE; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0030716258     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.596     Document Type: Article

References (32)

1. Chappell SA, Walsh T, Walker RA and Shaw JA (1997) Loss of heterozygosity at chromosome 6q in preinvasive and early invasive breast carcinomas. Br J Cancer 75: 1324-1329
2. Cullen KJ, Yee D, Sly WS, Pardue J, Hampton B, Lippman ME and Rosen N (1990) Insulin-like growth factor expression and function in human breast cancer. Cancer Res 50: 48-53
3. De Leon DD, Bakker B, Wilson DM, Hitz RL and Rosenfeld RG (1988) Demonstration of insulin-like growth factor (IGF-I and -II) receptors and binding protein in human breast cancer cell lines. Biochem Biophys Res Commun 152: 398-405
4. Dennis PA and Rifkin DB (1991) Cellular activation of latent transforming growth factor β requires binding to the cation-independent mannose 6-phosphate/insulin-like growth factor type II receptor. Proc Natl Acad Sci USA 88: 580-584
5. De Souza AT, Hankins GR, Washington MK, Fine RL, Orton TC and Jirtle RL (1995a) Frequent loss of heterozygosity on 6q at the mannose 6-phosphate/insulin-like growth factor II locus in human hepatocellular tumours. Oncogene 10: 1725-1729
6. De Souza AT, Hankins GR, Washington MK, Orton TC and Jirtle RL (1995b). M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity. Nature Genet 11: 447-449
7. Devilee P, van Vliet M, van Sloun P, Kuipers Dijkshoorn N, Hermans J, Pearson PL and Cornelisse CJ (1991) Allelotype of human breast carcinoma: a second major site for loss of heterozygosity is on chromosome 6q. Oncogene 6: 1705-1711
8. Ellis MJC, Singer C, Hornby A, Rasmussen A and Cullen KJ (1994) Insulin-like growth factor mediated stromal-epithelial interactions in human breast cancer. Breast Cancer Res Treat 31: 249-261
9. Ellis MJC, Leav BA, Yang Z, Rasmussen A, Pearce A, Zweibel JA, Lippman ME and Cullen KJ (1996) Affinity for the Insulin-Like Growth Factor II (IGF-II) Receptor inhibits autocrine IGF-II activity in MCF-7 breast cancer cells. Mol Endocrinol 10: 286-297
10. Elston CW and Ellis IO (1991) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19: 403-410
11. Graff JR, Herman JG, Lapidus RG, Chopra H, Xu R, Jarrard DF, Isaacs WB, Pitha PM, Davidson NE and Baylin SB (1995) E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res 55: 5195-5199
12. Hankins GR, De Souza AT, Bentley RC, Patel MR, Marks JR, Iglehart JD and Jirtle RL (1996) M6P/IGF2 receptor: a candidate breast tumour suppressor gene. Oncogene 12: 2003-2009
13. Hébert E, Herbelin C and Bougnoux P (1994) Analysis of the IGF-II receptor gene copy number in breast carcinoma. Br J Cancer 69: 120-124
14. Herman JG, Latif F, Weng Y, Lerman MI, Zbar B, Liu S, Samid D, Duan DSR, Gnarra JR, Linehan WM and Baylin SB (1994) Silencing of the VHL tumour-suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci USA 91: 9700-9704
15. Hol FA, Geurds MP, Hamel BC and Mariman ECM (1992) Improving the polymorphism content of the 3′ UTR of the human IGF2R gene. Hum Mol Genet 1: 347
16. Jirtle RL, Haag JD, Ariazi EA and Gould MN (1993) Increased mannose phosphate/insulin-like growth factor II receptor and transforming growth factor β1 levels during monoterpene-induced regression of mammary tumours. Cancer Res 53: 3849-3852
17. Kornfeld S (1992) Structure and function of the mannose 6-phosphate/insulin like growth factor II receptor. Annu Rev Biochem 61: 307-330
18. Lagios MD (1990) Duct carcinoma in situ: pathology and treatment. Surg Clin N Am 70: 853-871
19. Laureys G, Barton DE, Ullrich A and Francke U (1988) Chromosomal mapping of the gene for the type II insulin-like growth factor receptor/cation-independent mannose 6-phosphate receptor in man and mouse. Genomics 3: 224-229
20. n dinucleotide repeat assay for evaluating loss of allelic heterozygosity in small and archival human brain tumour specimens. Am J Pathol 141: 777-782
21. Menasce LP, Orphanous V, Santibanez-Koref M, Boyle JM and Harrison CJ (1994) Common region of deletion on the long arm of chromosome 6 in non-Hodgkin's lymphoma and acute lymphoblastic leukaemia. Genes Chrom Cancer 10: 286-288
22. Merlo A, Gabrielson E, Mabry M, Vollmer R, Baylin SB and Sidransky D (1994) Homozygous deletion on chromosome 9p and loss of heterozygosity on 9q, 6p, and 6q in primary human small cell lung cancer. Cancer Res 54: 2322-2326
23. Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB and Sidransky D (1995) 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nature Med 1: 686-692
24. Millikin D, Meese E, Vogelstein B, Witkowski C and Trent J (1991) Loss of heterozygosity for loci on the long arm of chromosome 6 in human malignant melanoma. Cancer Res 51: 5449-5453
25. Morita R, Saito S, Ishikawa J, Ogawa O, Yoshida O, Yamakawa K and Nakamra Y (1991) Common regions of deletion on chromosome 5q, 6q, and 10q in renal cell carcinoma. Cancer Res 51: 5817-5820
26. National Coordinating Group for Breast Screening Pathology (1995) Pathology Reporting in Breast Cancer Screening, 2nd edn. NHSBSP: Sheffield, UK
27. Orphanos V, McGown G, Hey Y, Boyle JM and Santibanez-Koref M (1995) Proximal 6q, a region showing allele loss in primary breast cancer. Br J Cancer 71: 290-293
28. Paik S (1992) Expression of IGF-I and IGF-II mRNA in breast tissue. Breast Cancer Res Treat 22: 31-38
29. Rodabaugh KJ, Blanchard G, Welch WR, Bell DA, Berkowitz RS and Mok SC (1995) Detailed deletion mapping of chromosome 6q in borderline epithelial ovarian tumors. Cancer Res 55: 2169-2172
30. Singer C, Rasmussen A, Smith HS, Lippman ME, Lynch HT and Cullen KJ (1995) Malignant breast epithelium selects for insulin-like growth factor II expression in breast stroma: evidence of paracrine function. Cancer Res 55: 2448-2454
31. Shaw JA, Walsh T, Chappell SA, Carey N, Johnson K and Walker RA (1996) Microsatellite instability in early sporadic breast cancer. Br J Cancer 73: 1393-1397
32. Zhoa Y, Escot C, Maudelonde T, Puech C, Rouanet P and Rochefort H (1993) Correlation between mannose-6-phosphate/IGFII receptor and cathepsin D RNA levels by in situ hybridization in benign and malignant mammary tumours. Cancer Res 53: 2901-2905